Roopa Industries
BSE: ROOPAIND · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Roopa Industries's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Roopa Industries Limited is an Indian manufacturer specialising in bulk drugs, active pharmaceutical ingredients (APIs), and intermediate chemicals. Based in Hyderabad, the company supplies chemical compounds to larger pharmaceutical formulation manufacturers for both domestic and international markets.
Business Model
The company generates revenue by manufacturing and supplying essential chemical intermediates and APIs to the pharmaceutical industry. It leverages process research and development to optimise chemical synthesis and maintain cost-effective production standards.
Growth Outlook
Growth is driven by the company's focus on process research and development to enhance manufacturing efficiency. The firm aims to strengthen its position as a reliable supplier within the competitive small-cap chemical and pharmaceutical sector.
Key Risks
- Regulatory Compliance. The company faces stringent environmental and safety regulations inherent to the chemical manufacturing industry.
- Input Cost Volatility. Fluctuations in the prices of raw materials and chemical precursors can significantly impact profit margins.
- Market Competition. As a small-cap player, the company faces intense competition from larger, well-capitalised pharmaceutical and chemical manufacturers.
- Operational Concentration. Reliance on a specific manufacturing facility in Telangana creates potential risks related to site-specific operational disruptions.
Start your research today
Unlock AI insights, financials, peers and live data on Roopa Industries and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Roopa IndustriesROOPAIND | ₹38 Cr | — | — | — | 6.0% | — | — | -15.6% |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Mar 2026
Financials
Roopa Industries
BSE: ROOPAIND · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Roopa Industries's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Roopa Industries Limited is an Indian manufacturer specialising in bulk drugs, active pharmaceutical ingredients (APIs), and intermediate chemicals. Based in Hyderabad, the company supplies chemical compounds to larger pharmaceutical formulation manufacturers for both domestic and international markets.
Business Model
The company generates revenue by manufacturing and supplying essential chemical intermediates and APIs to the pharmaceutical industry. It leverages process research and development to optimise chemical synthesis and maintain cost-effective production standards.
Growth Outlook
Growth is driven by the company's focus on process research and development to enhance manufacturing efficiency. The firm aims to strengthen its position as a reliable supplier within the competitive small-cap chemical and pharmaceutical sector.
Key Risks
- Regulatory Compliance. The company faces stringent environmental and safety regulations inherent to the chemical manufacturing industry.
- Input Cost Volatility. Fluctuations in the prices of raw materials and chemical precursors can significantly impact profit margins.
- Market Competition. As a small-cap player, the company faces intense competition from larger, well-capitalised pharmaceutical and chemical manufacturers.
- Operational Concentration. Reliance on a specific manufacturing facility in Telangana creates potential risks related to site-specific operational disruptions.
Start your research today
Unlock AI insights, financials, peers and live data on Roopa Industries and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026